Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Momentum grows for FDA reform

This article was originally published in Clinica

Executive Summary

"Meaningful regulatory reform legislation" must be enacted in the US before a US/EU Mutual Recognition Agreement can be concluded for medical devices. This was one of the recommendations to emerge from the Transatlantic Business Dialogue held in Spain on November 10th-11th. Over 100 business leaders, including representatives from the medical device industry, met in Seville to discuss ways in which barriers to trade could be removed (see Clinica No 678, p 6).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094107

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel